ConductScience.org, home

Paper41550643

Assay development and screening of inhibitors targeting the SARS-CoV-2 2'-O-methyltransferase NSP16.

Cao M and 9 others. Pharm Sci Adv, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Assay development and screening of inhibitors targeting the SARS-CoV-2 2'-O-methyltransferase NSP16. Papers, record 41550643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41550643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assay development and screening of inhibitors targeting the SARS-CoV-2 2'-O-methyltransferase NSP16.
PubMed
Journal
Pharm Sci Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-05-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cao MMengtong
2Trieshmann CWCarl W
3Samrat SKSubodh Kumar
4Li HHongmin
5Wu YYifei
6Maher SPSteven P
7Bae AAAngela A
8Xie ZRZhong-Ru
9Hogan RJRobert J
10Zheng YGY George

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R41 AI177149NIAID NIH HHSUnited StatesR41AI177149PubMedNIH RePORTER
R01 AI161845NIAID NIH HHSUnited StatesR01AI161845PubMed and NIHNIH RePORTER
R01 AI175435NIAID NIH HHSUnited StatesR01AI175435PubMedNIH RePORTER
R56 AI131669NIAID NIH HHSUnited StatesR01AI131669PubMed and NIHNIH RePORTER
R01 AI131669NIAID NIH HHSUnited StatesR01AI131669PubMed and NIHNIH RePORTER
R21 AI158176NIAID NIH HHSUnited StatesR21AI158176PubMedNIH RePORTER
R35 GM149230NIGMS NIH HHSUnited StatesR35GM149230PubMed and NIHNIH RePORTER
R56AI131669NIHNIH RePORTER

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132007145Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet2020https://conductscience.org/library/papers/32007145PubMed
215140959Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase.J Virol2004https://conductscience.org/library/papers/15140959PubMed
334762019Structural screening into the recognition of a potent inhibitor against non-structural protein 16: a molecular simulation to inhibit SARS-CoV-2 infection.J Biomol Struct Dyn2022https://conductscience.org/library/papers/34762019PubMed
434096718OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space.J Chem Theory Comput2021https://conductscience.org/library/papers/34096718PubMed
532571880Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2).J Biol Chem2020https://conductscience.org/library/papers/32571880PubMed
637429335Methyl gallate: Review of pharmacological activity.Pharmacol Res2023https://conductscience.org/library/papers/37429335PubMed
736040262Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.Protein Sci2022https://conductscience.org/library/papers/36040262PubMed
834751829Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16).J Genet Eng Biotechnol2021https://conductscience.org/library/papers/34751829PubMed
916828802RNA recognition and cleavage by the SARS coronavirus endoribonuclease.J Mol Biol2006https://conductscience.org/library/papers/16828802PubMed
1023602469Viral precursor polyproteins: keys of regulation from replication to maturation.Curr Opin Virol2013https://conductscience.org/library/papers/23602469PubMed
1128031370Binding of the Methyl Donor S-Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus 2'-O-Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10.J Virol2017https://conductscience.org/library/papers/28031370PubMed
1232397643Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.Viruses2020https://conductscience.org/library/papers/32397643PubMed
1339325663The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.FEBS J2025https://conductscience.org/library/papers/39325663PubMed
1420463816Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.PLoS Pathog2010https://conductscience.org/library/papers/20463816PubMed
1535225672Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?J Virol2022https://conductscience.org/library/papers/35225672PubMed
1633919870Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.Biomolecules2021https://conductscience.org/library/papers/33919870PubMed
1737060263A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.Emerg Microbes Infect2023https://conductscience.org/library/papers/37060263PubMed
1835259661Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes.Comput Biol Chem2022https://conductscience.org/library/papers/35259661PubMed
1915220459Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities.J Virol2004https://conductscience.org/library/papers/15220459PubMed
2033317409Multitarget in silico studies of Ocimum menthiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation.J Biomol Struct Dyn2022https://conductscience.org/library/papers/33317409PubMed

See all 55 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42921030Structure-Based Design of New Nonpeptidic Covalent Mpro Inhibitors against SARS-CoV‑2 and Omicron Variants.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42921030PubMed
42357309Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals.Pharmaceutics2026https://conductscience.org/library/papers/42357309PubMed
42048414Selective Targeting of Protein Arginine Methyltransferase 1 (PRMT1) Mutant Activity by a Small Molecule Activation Strategy.ACS Chem Biol2026https://conductscience.org/library/papers/42048414PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CAP110487PubTator's text mininghttps://conductscience.org/library/genes/10487

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41550643

GET https://conductscience.org/api/papers/v1/41550643/references?page=2